INIS
assessments
17%
blood
9%
cancer
13%
chemotherapy
12%
collagen
8%
comparative evaluations
14%
defects
11%
detection
7%
diseases
35%
evaluation
13%
glycoproteins
7%
hemophilia
33%
hemostatics
9%
laboratories
19%
levels
25%
management
8%
mutations
9%
netherlands
9%
patients
100%
phenotype
13%
populations
10%
reviews
11%
risks
9%
screening
8%
sensitivity
6%
testing
10%
thrombin
12%
thrombosis
9%
transfusions
6%
women
7%
Keyphrases
Bleeding
16%
Bleeding Assessment Tool
6%
Bleeding Disorders
18%
Cancer Patients
7%
Chemotherapy
8%
Clinical Practice
5%
Desmopressin (DDAVP)
13%
Hemophilia
25%
Hemophilia B
8%
Hemostasis
14%
Integrin
7%
Mild Bleeding Disorders
11%
Multi-parameter
7%
Netherlands
9%
Non-severe Haemophilia
11%
Pharmacokinetics
11%
Platelet Function Analyzer
7%
Platelet Function Disorders
5%
Platelets
18%
Primary Immunodeficiency
7%
Severe Haemophilia A
6%
Thrombin Generation
6%
Thrombin Generation Assay
6%
Thrombocytopenia
12%
Thrombosis
8%
Thrombus Formation
15%
Unknown Cause
15%
Von Willebrand Disease
22%
Von Willebrand Factor
19%
Whole Genome Sequencing
7%
Medicine and Dentistry
Bleeding
21%
Bleeding Disorder
32%
Blood Clotting
10%
Blood Clotting Factor 8
7%
Blood Stasis
14%
Desmopressin
13%
Fibrinogen
5%
Fibrinolysis
5%
Glycoprotein VI
7%
Haemophilia A
28%
Haemophilia B
8%
Hemostat
8%
Integrin
8%
Laboratory Test
7%
Odds Ratio
5%
Pharmacokinetics
11%
Platelet
15%
Thrombocyte Function
13%
Thrombocyte Transfusion
5%
Thrombocytopenia
9%
Thrombosis
8%
Von Willebrand Disease
15%
Von Willebrand Factor
12%